This achievement becomes even more historic as LMIL–Renalyx has now received the globally recognised CE marking, making it ...
Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today released the following note authored by ...
Lords Mark Industries Ltd. (LMIL) and Renalyx secured the Class C licence to manufacture the Worlds First AI-Based Smart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback